Nothing Special   »   [go: up one dir, main page]

BR112018001292A2 - métodos para melhor liberação de agentes ativos a tumores - Google Patents

métodos para melhor liberação de agentes ativos a tumores

Info

Publication number
BR112018001292A2
BR112018001292A2 BR112018001292A BR112018001292A BR112018001292A2 BR 112018001292 A2 BR112018001292 A2 BR 112018001292A2 BR 112018001292 A BR112018001292 A BR 112018001292A BR 112018001292 A BR112018001292 A BR 112018001292A BR 112018001292 A2 BR112018001292 A2 BR 112018001292A2
Authority
BR
Brazil
Prior art keywords
methods
tumors
active agents
better release
agents
Prior art date
Application number
BR112018001292A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR112018001292A2 publication Critical patent/BR112018001292A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

a presente invenção diz respeito à entrega de agentes através da pele. os métodos para fornecer agentes, tais como agentes bioativos, são contemplados pela presente invenção. especificamente, métodos para a entrega direcionada de agentes para uma ou mais áreas da epiderme e, assim, para um ou mais tumores de câncer são descritos.
BR112018001292A 2015-07-24 2016-07-22 métodos para melhor liberação de agentes ativos a tumores BR112018001292A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
BR112018001292A2 true BR112018001292A2 (pt) 2018-09-11

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001292A BR112018001292A2 (pt) 2015-07-24 2016-07-22 métodos para melhor liberação de agentes ativos a tumores

Country Status (15)

Country Link
US (3) US10806913B2 (pt)
EP (2) EP3925599A1 (pt)
JP (1) JP7082041B2 (pt)
KR (1) KR20180035209A (pt)
CN (2) CN107921248A (pt)
AU (3) AU2016297823B2 (pt)
BR (1) BR112018001292A2 (pt)
CA (1) CA2991455C (pt)
DK (1) DK3325080T3 (pt)
ES (1) ES2891523T3 (pt)
HU (1) HUE056410T2 (pt)
MX (2) MX2018000166A (pt)
PL (1) PL3325080T3 (pt)
RU (1) RU2719943C2 (pt)
WO (1) WO2017019526A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017019535A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for lymphatic delivery of active agents
BR112018001292A2 (pt) * 2015-07-24 2018-09-11 Kimberly Clark Co métodos para melhor liberação de agentes ativos a tumores
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
CN110891635B (zh) 2017-05-17 2023-07-04 麻省理工学院 自致动制品
CA3066991A1 (en) 2017-07-10 2019-01-17 Basf Se Mixtures comprising an urease inhibitor (ui) and a nitrification inhibitor such as 2-(3,4-dimethyl-1h-pyrazol-1-yl)succinic acid (dmpsa) or 3,4-dimethyl pyrazolium glycolate (dmpg)
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
CN112512502A (zh) * 2018-05-31 2021-03-16 索伦托药业有限公司 靶向淋巴系统的药物输送方法
US20210308440A1 (en) * 2018-09-24 2021-10-07 L'oreal Device comprising microneedles for skin-coloring
MX2022006786A (es) 2019-12-05 2022-07-19 Sorrento Therapeutics Inc Método de tratamiento de cáncer mediante la administración de un agente terapéutico anti-pd-1 o anti-pd-l1 mediante un dispositivo de administración linfática.
US20240090908A1 (en) 2021-01-22 2024-03-21 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines and methods of use thereof
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
EP4352100A1 (en) 2021-06-09 2024-04-17 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
WO2023023074A1 (en) 2021-08-18 2023-02-23 Sorrento Therapeutics, Inc. Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
PL201222B1 (pl) 2000-06-01 2009-03-31 Watson Pharmaceuticals Preparat transdermalny lazoksyfenu, urządzenie do podawania lazoksyfenu, oraz zastosowanie lazoksyfenu
CA2460063C (en) * 2001-09-12 2010-07-20 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
CA2529048A1 (en) * 2003-06-13 2005-02-24 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
BRPI0414014A (pt) 2003-08-26 2006-10-24 Becton Dickinson Co métodos para distribuição intradérmica de agentes terapêuticos
EP1802258A4 (en) * 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
US20070088414A1 (en) 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
CA2612005C (en) * 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
AU2011288209C1 (en) 2010-04-28 2016-03-24 Kimberly-Clark Worldwide, Inc. Injection molded microneedle array and method for forming the microneedle array
US9522262B2 (en) 2010-04-28 2016-12-20 Kimberly-Clark Worldwide, Inc. Medical devices for delivery of siRNA
MX345837B (es) 2010-04-28 2017-02-16 Kimberly-Clark Worldwide Incorporated Dispositivo para la entrega de un medicamento para la artritis reumatoide.
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
KR102058568B1 (ko) * 2011-10-17 2020-01-22 메사추세츠 인스티튜트 오브 테크놀로지 세포 내 전달
KR20220051429A (ko) * 2011-10-27 2022-04-26 소렌토 쎄라퓨틱스, 인코포레이티드 고점도 생체활성 제제의 경피 전달 방법
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
AU2013316706B2 (en) * 2012-09-13 2018-06-21 Avraham Amir Delivery devices and methods for skin augmentation
PL2897620T3 (pl) * 2012-09-21 2020-11-02 Intensity Therapeutics, Inc Sposób leczenia nowotworu złośliwego
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
CN105073179B (zh) 2013-02-28 2019-03-19 索伦托治疗有限公司 经皮药物递送装置
EP2961469A4 (en) 2013-02-28 2016-10-26 Kimberly Clark Co DEVICE FOR DELIVERY OF MEDICAMENT
CN105209104A (zh) 2013-05-23 2015-12-30 金伯利-克拉克环球有限公司 具有改进的开放通道横截面几何形状的微针
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
WO2017019535A2 (en) * 2015-07-24 2017-02-02 Kimberly-Clark Worldwide, Inc. Methods for lymphatic delivery of active agents
BR112018001292A2 (pt) * 2015-07-24 2018-09-11 Kimberly Clark Co métodos para melhor liberação de agentes ativos a tumores

Also Published As

Publication number Publication date
DK3325080T3 (da) 2021-10-04
HUE056410T2 (hu) 2022-02-28
US20180193624A1 (en) 2018-07-12
JP2018521755A (ja) 2018-08-09
US20210052871A1 (en) 2021-02-25
JP7082041B2 (ja) 2022-06-07
AU2022275397A1 (en) 2023-01-05
CN107921248A (zh) 2018-04-17
KR20180035209A (ko) 2018-04-05
US10806913B2 (en) 2020-10-20
RU2018104102A3 (pt) 2019-11-06
US20240238570A1 (en) 2024-07-18
MX2018000166A (es) 2018-03-26
EP3925599A1 (en) 2021-12-22
EP3325080B1 (en) 2021-09-01
AU2016297823A1 (en) 2018-02-15
ES2891523T3 (es) 2022-01-28
AU2016297823B2 (en) 2020-10-22
EP3325080A4 (en) 2019-04-17
AU2021200146A1 (en) 2021-03-18
WO2017019526A2 (en) 2017-02-02
AU2021200146B2 (en) 2022-08-25
CA2991455A1 (en) 2017-02-02
CA2991455C (en) 2023-10-10
RU2018104102A (ru) 2019-08-27
MX2022014277A (es) 2022-12-07
EP3325080A2 (en) 2018-05-30
PL3325080T3 (pl) 2022-01-24
RU2719943C2 (ru) 2020-04-23
CN118902979A (zh) 2024-11-08

Similar Documents

Publication Publication Date Title
BR112018001292A2 (pt) métodos para melhor liberação de agentes ativos a tumores
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
CY1124595T1 (el) Ρυθμιση δραστικοτητας συμπληρωματος
CL2019002304A1 (es) Compuestos para el tratamiento del cáncer.
CL2019002461A1 (es) Arn terapéutico.
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
ECSP17073743A (es) Moduladores de k-ras
CO2017011183A2 (es) Inhibidores de indolamina-2,3-dioxigenasa composiciones que los contienen y métodos de preparación
CL2017001459A1 (es) Biarilo compuestos útiles para el tratamiento de enfermedades humanas en oncología, neurología e inmunología
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
CO2017004736A2 (es) Péptidos macrociclicos útiles como inmunomoduladores
CL2018003265A1 (es) Modulares del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos.
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
CR20150316A (es) Compuestos y sus métodos de empleo
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CY1124761T1 (el) Ρυθμιστες της δραστικοτητας του συμπληρωματος
BR112016012713A2 (pt) Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
CY1122968T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει μια ενωση διαμινο-ετεροκυκλικου καρβοξαμιδιου ως δραστικο συστατικο
EA201591925A1 (ru) Терапевтические композиции и их применение

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SORRENTO THERAPEUTICS, INC. (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements